Cleared Traditional

K200350 - MyHip Planner & Verifier

K200350 is the FDA 510(k) clearance for MyHip Planner & Verifier by Medacta International S.A.. It is a Class 2 Radiology device (product code LLZ) cleared through the Traditional 510(k) pathway after a 266-day FDA review.

K200350 · Medacta International S.A. · Radiology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Nov 2020
Decision
266d
Days
Class 2
Risk

K200350 is an FDA 510(k) clearance for the MyHip Planner & Verifier. Classified as System, Image Processing, Radiological within the LLZ classification (a category encompassing advanced image processing and PACS-adjacent software), Class II - Special Controls.

Submitted by Medacta International S.A. (Castel San Pietro (Ch), CH). The FDA issued a Cleared decision on November 4, 2020 after a review of 266 days - an extended review cycle.

This device falls under the Radiology FDA review panel, regulated under 21 CFR 892.2050 - the FDA radiology and imaging software oversight framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Incremental AI imaging tool. Moderate-to-high equivalence dependency. Overall, this clearance reflects a predicate-aligned approval typical of modern AI radiology extensions - not a novel clinical breakthrough, but a validated iteration within an established regulatory category.

View all Medacta International S.A. devices

Submission Details

510(k) Number K200350 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received February 12, 2020
Decision Date November 04, 2020
Days to Decision 266 days
Submission Type Traditional
Review Panel Radiology (RA)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
159d slower than avg
Panel avg: 107d · This submission: 266d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code LLZ System, Image Processing, Radiological
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 892.2050
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Radiology devices follow this clearance model.

Regulatory Consultant

Medacta USA
Chris Lussier

The regulatory consultant manages the 510(k) submission process on behalf of the applicant - coordinating technical documentation, predicate strategy and FDA communications. Identifying the consultant behind a submission is a key signal for competitive regulatory intelligence.

Regulatory Peers - LLZ System, Image Processing, Radiological

All 1092
Devices cleared under the same product code (LLZ) and FDA review panel - the closest regulatory comparables to K200350.
DBSWIN, VISTAEASY
K203287 · D?rr Dental SE · Nov 2020
PROView
K193306 · GE Medical Systems SCS · Nov 2020
Neuro.Al Algorithm
K200750 · Terarecon,Inc. · Nov 2020
CloudVue
K203058 · International Medical Solutions, Inc. · Oct 2020
OrthoNext Platform System
K202519 · Orthofix Srl · Oct 2020
EzOrtho
K202948 · Ewoosoft Co., Ltd. · Oct 2020